KIROMIC BIOPHARMA INC (KRBP) Forecast, Price Target & Analyst Ratings
NASDAQ:KRBP • US4976342042
1.45 USD
-0.13 (-8.23%)
At close: Sep 13, 2023
0.6931 USD
-0.76 (-52.2%)
After Hours: 9/13/2023, 8:21:06 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KIROMIC BIOPHARMA INC (KRBP).
Forecast Snapshot
Consensus Price Target
$0.00
-100.00% Downside
Next Earnings Forecast
Release DateNov 13, 2023
PeriodQ3 / 2023
EPS Estimate-$0.44
Revenue Estimate
ChartMill Buy Consensus
0.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $1.45 to mean target of $0.00, Based on 0 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 13, 2023
PeriodQ3 / 2023
EPS Estimate-$0.44
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q42.67%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | |||||||
| EBITDA YoY % growth | -5.27M | -3.1M 41.18% | -3.62M -16.77% | -19M -424.86% | -24.84M -30.74% | -29.45M -18.56% | N/A -22.53% | N/A -7.31% | |
| EBIT YoY % growth | -5.39M | -3.18M 41.00% | -3.71M -16.67% | -19.2M -417.52% | -25.31M -31.82% | -31.12M -22.96% | N/A -20.83% | N/A -7.22% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 96.10% | N/A 33.48% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.44 42.67% | -0.50 12.50% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
KIROMIC BIOPHARMA INC / KRBP Forecast FAQ
Can you provide the upcoming earnings date for KIROMIC BIOPHARMA INC?
KIROMIC BIOPHARMA INC (KRBP) will report earnings on 2023-11-13, after the market close.
Can you provide the consensus estimates for KIROMIC BIOPHARMA INC next earnings?
The consensus EPS estimate for the next earnings of KIROMIC BIOPHARMA INC (KRBP) is -0.44 USD and the consensus revenue estimate is 0 USD.